A detailed history of Hancock Whitney Corp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 20,151 shares of LNTH stock, worth $1.58 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,151
Previous 5,512 265.58%
Holding current value
$1.58 Million
Previous $341,000 267.74%
% of portfolio
0.04%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

BUY
$51.07 - $68.26 $747,613 - $999,258
14,639 Added 265.58%
20,151 $1.25 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $8,395 - $11,761
-151 Reduced 2.67%
5,512 $341,000
Q3 2023

Nov 13, 2023

SELL
$60.27 - $90.75 $6,328 - $9,528
-105 Reduced 1.82%
5,663 $393,000
Q2 2023

Nov 13, 2023

SELL
$82.41 - $99.65 $176,357 - $213,251
-2,140 Reduced 27.06%
5,768 $484,000
Q2 2023

Aug 10, 2023

SELL
$82.41 - $99.65 $176,357 - $213,251
-2,140 Reduced 27.06%
5,768 $484,000
Q1 2023

Nov 13, 2023

SELL
$47.76 - $82.86 $50,816 - $88,163
-1,064 Reduced 11.86%
7,908 $652,000
Q1 2023

May 16, 2023

SELL
$47.76 - $82.86 $50,816 - $88,163
-1,064 Reduced 11.86%
7,908 $653,000
Q4 2022

Nov 13, 2023

BUY
$48.76 - $77.67 $156,227 - $248,854
3,204 Added 55.55%
8,972 $457,000
Q4 2022

Feb 03, 2023

SELL
$48.76 - $77.67 $1,219 - $1,941
-25 Reduced 0.28%
8,972 $457,000
Q3 2022

Oct 26, 2022

SELL
$61.42 - $86.29 $123,269 - $173,184
-2,007 Reduced 18.24%
8,997 $633,000
Q2 2022

Aug 08, 2022

SELL
$55.54 - $72.65 $357,233 - $467,284
-6,432 Reduced 36.89%
11,004 $727,000
Q1 2022

May 12, 2022

SELL
$24.28 - $56.64 $89,714 - $209,284
-3,695 Reduced 17.49%
17,436 $964,000
Q4 2021

Jan 25, 2022

SELL
$22.54 - $30.44 $9,038 - $12,206
-401 Reduced 1.86%
21,131 $610,000
Q3 2021

Nov 04, 2021

BUY
$24.23 - $28.59 $250,077 - $295,077
10,321 Added 92.06%
21,532 $553,000
Q2 2021

Aug 09, 2021

SELL
$19.51 - $27.64 $6,223 - $8,817
-319 Reduced 2.77%
11,211 $310,000
Q1 2021

May 14, 2021

BUY
$13.77 - $21.66 $158,768 - $249,739
11,530 New
11,530 $246,000
Q4 2020

Feb 09, 2021

SELL
$10.75 - $14.91 $126,301 - $175,177
-11,749 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$11.98 - $16.34 $5,618 - $7,663
469 Added 4.16%
11,749 $149,000
Q2 2020

Jul 30, 2020

SELL
$10.34 - $15.51 $145,059 - $217,589
-14,029 Reduced 55.43%
11,280 $161,000
Q1 2020

May 08, 2020

BUY
$9.11 - $20.05 $83,821 - $184,480
9,201 Added 57.12%
25,309 $323,000
Q4 2019

Feb 06, 2020

SELL
$18.47 - $24.03 $175,705 - $228,597
-9,513 Reduced 37.13%
16,108 $330,000
Q3 2019

Oct 29, 2019

SELL
$21.01 - $28.94 $129,778 - $178,762
-6,177 Reduced 19.43%
25,621 $642,000
Q2 2019

Aug 29, 2019

BUY
$23.33 - $28.3 $522,778 - $634,146
22,408 Added 238.64%
31,798 $900,000
Q1 2019

May 13, 2019

BUY
$14.93 - $25.1 $140,192 - $235,689
9,390 New
9,390 $230,000
Q2 2018

Aug 14, 2018

SELL
$13.65 - $18.7 $1.01 Million - $1.39 Million
-74,136 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$14.85 - $24.3 $456,815 - $747,516
-30,762 Reduced 29.33%
74,136 $1.18 Million
Q4 2017

Feb 12, 2018

BUY
$17.4 - $23.4 $648,689 - $872,375
37,281 Added 55.14%
104,898 $2.15 Million
Q3 2017

Nov 14, 2017

BUY
$15.5 - $19.15 $1.05 Million - $1.29 Million
67,617
67,617 $1.2 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.4B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.